Welcome to JDD Corner, your gateway to a world of dermatology knowledge and insights! JDD Corner is a curated collection of video abstracts, editor picks, Key Opinion Leader (KOL) spotlights, trending articles, and much more. Whether you are a dermatologist, a skincare enthusiast, or simply curious about the latest advancements in dermatology, JDD Corner is your one-stop destination for staying informed and up-to-date with the most exciting developments in the field. Explore our carefully selected content and immerse yourself in the dynamic world of dermatology. Welcome to JDD Corner!
JDD Corner
JDD Corner
Video Abstracts
Introducing an Exciting NEW Opportunity for Our Authors to Connect with Our Readership through a Cutting-Edge Media Channel! Email us at editorial@jddonline.com to get started!
NEW! VIDEO ABSTRACT
Efficacy of a Dual-Serum Cosmetic System in Women With Female Pattern Hair Loss
Hair loss is a widespread condition with a potentially severe psychological burden, especially among women. The chance of suffering from female alopecia increases with menopause, and topical treatments beyond minoxidil are scarce. Over the past several years, new combinations of natural ingredients and patented mixtures have shown promising results to improve hair shedding, thus helping recover self-esteem and confidence.
NEW! VIDEO ABSTRACT
Clinical Evaluation of a Thiamidol-Based Regimen With SPF Compared With SPF Alone for Facial Hyperpigmentation
Hyperpigmentation disorders are common skin concerns that negatively impact patient quality of life and self-perception. Hyperpigmentation results from the overproduction of melanin via a multi-step process with a rate-limiting step catalyzed by tyrosinase.
NEW! VIDEO ABSTRACT
Molecular Insights: Immune and Barrier Dysregulation in Seborrheic Dermatitis
Seborrheic dermatitis(SD) is a chronic inflammatory skin disease that affects sebaceous areas, typically the face and scalp, with an estimated prevalence of 2% to 5%. It is thought to result from a combination of immune dysregulation, barrier dysfunction, and colonization with Malassezia species.1,2
NEW! VIDEO ABSTRACT
Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation
Cutaneous hyperpigmentation, which includes melasma, post-inflammatory hyperpigmentation, and solar lentigines, significantly impacts patients’ quality of life.
NEW! VIDEO ABSTRACT
Retrospective Review of Dermal Safety Studies of Organic Sunscreens
Sunscreens can reduce skin cancer and sunburn. Recent studies on dermal penetration have raised concerns about the safety of sunscreens with organic ultraviolet (UV) filters.
NEW! VIDEO ABSTRACT
Perceptions and Recommendations for Sunscreen: A Cross-Sectional Survey of United States Dermatology Healthcare Providers
The dermatology HCPs in this survey strongly support sunscreen use and believe that FDA-approved sunscreens are effective and safe. The social media findings highlight a continued need to improve education on sunscreen use and increase counseling from clinicians on sun protection behaviors.
Author Spotlight
Our current Author Spotlight features Nada Elbuluk, MD, MSc, FAAD, one of the co-authors of Public Interest in Hyperpigmentation: Insights From a Google Trends Analysis, published in our July 2026 issue. In addition to the article, Dr. Elbuluk also provided insight about the current state of dermatology and how the field is adapting to new advances in technology and treatments.
Read More
Trending Articles
Decreased Nonmelanoma Skin Cancer Risk With Interleukin-17 and Interleukin-23 Inhibitors Versus TNF-α Inhibitors in Psoriasis
People with psoriasis are at increased risk for nonmelanoma skin cancers (NMSC) and melanoma. Conventional immunosuppressants and TNF-α inhibitors may further increase skin malignancies, while the risks associated with other biologics are less clear. This study aimed to determine skin malignancy risks in psoriasis patients treated with cyclosporine, methotrexate, TNF-α inhibitors, IL-12/23, IL-17, and IL-23 inhibitors.
Read More
Clascoterone Cream 1% Is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial
Papulopustular rosacea (PPR) is a chronic inflammatory facial dermatosis with a need for well-tolerated and effective topical therapies. Clascoterone cream 1% is an androgen receptor inhibitor and a promising novel treatment for PPR.
Read More
Molluscum Contagiosum in the Pediatric Population: Expert Consensus Guidance on Prevention and Treatment
Molluscum contagiosum (MC), caused by the molluscum contagiosum virus, is a common viral skin infection in children. MC may persist for months to years and can substantially impair the quality of life for affected children and their families through discomfort, pruritus, cosmetic concerns, social stigma, and household transmission. Newer US Food and Drug Administration (FDA)-approved therapies have demonstrated patient-acceptable clearance rates, providing clinicians with additional options to treat pediatric MC. The paper summarized literature on MC in childhood and provided evidence-based guidance to help clinicians manage pediatric MC.
Read More
Clinical Characteristics and Time to Onset of JAK-Inhibitor–Associated Acne: A Retrospective Chart Review Study
Acne is a common cutaneous adverse event associated with Janus kinase (JAK) inhibitors, with incidence varying across agents. Substantial increase in JAK inhibitor use has been accompanied by presentation of acne as a side effect, yet data describing its clinical features remain limited. This paper aims to characterize the demographic features, timing, and clinical presentation of acne associated with oral JAK inhibitor therapy across multiple agents.
Read More
Impact of Intermittent Fasting, Keto Diet vs Continuous Caloric Restriction on Psoriasis Severity: A Systematic Review and Meta-Analysis Protocol
Psoriasis is a chronic immune‑mediated inflammatory skin disease that is strongly associated with metabolic dysregulation and excess adiposity. Dietary strategies that reduce energy intake either by continuous daily caloric restriction (CCR) or time‑limited/periodic intake such as intermittent fasting (IF) or ketogenic diets (Keto) may improve psoriasis severity through weight loss, metabolic improvements, alterations in gut microbiota, and immune-metabolic effects.
Read More
GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity
Psoriasis is a chronic inflammatory skin disorder known to be linked to type 2 diabetes mellitus (T2DM), with 11.6% of psoriasis patients having comorbid T2DM.1 Glucagon-like peptide-1 receptor agonists (GLP-1 RA) effectively treat T2DM, and recent studies demonstrate their potential role in modulating systemic inflammation for psoriasis treatment.2
Read More
Recent News
Editor's Picks
Video Pearls
Tough Day at the Office: Lupus, Sarcoidosis, and a Side of Morphea
Watch as Dr. Friedman shares basic principles to managing three distinct diseases – cutaneous lupus, sarcoidosis and linear morphea. Learn why you need to do a good review of organ systems and be prepared to phone a friend (or more) across the aisle in medicine.
Tips for Providing Better Atopic Dermatitis Care
With the growing list of therapeutic options, Dr. Friedman encourages clinicians to go back to the basics and address one of the greatest challenges — treatment adherence.
Acne and Diet
Adam Friedman, professor and chair of dermatology at GW School of Medicine and Health Sciences. Dr. Friedman says acne is an evidence-based example of the saying “you are what you eat.”
Crushing It In The Capital: Lessons From Residency Translated
Dr. Friedman provides his tips for remaining calm during the craziest of office visits. He also shares why being fun, creative and an off-label bandit matters.
New Innovations in Hyperpigmentation
Dr. Chilukuri outlines at-home and in-office treatments to address hyperpigmentation, including newly developed therapies.
